这篇荟萃分析系统评价了动脉内溶栓(IAT)辅助血管内取栓(EVT)治疗大血管闭塞性卒中(LVOS)的疗效。研究纳入6项RCTs(n=1,974)，发现IAT显著提高90天优良功能预后(mRS=0-1)几率(OR=1.47,95%CI=1.21-1.80)，尤其在前循环卒中(OR=1.48)和阿替普酶组(OR=1.94)效果更显著，且不增加症状性 ...

PHOENIX -- Selected stroke patients did not benefit clinically from having the window of tenecteplase therapy extended beyond the first few hours of stroke onset, the randomized TIMELESS trial found.

MENLO PARK, Calif.--(BUSINESS WIRE)--RapidAI, the worldwide leader in advanced imaging for stroke, today announced that Rapid LVO has received Food and Drug Administration (FDA) clearance for ...

Bringing stroke patients straight to the angiography suite of a hospital capable of endovascular therapy reduced hospital delays and improved care for people with suspected large vessel occlusions ...

Please provide your email address to receive an email when new articles are posted on . The RapidAI software successfully processed and identified more eligible large vessel occlusion cases vs. VizAI.

The US Food and Drug Administration (FDA) has granted clearance to the Rapid LVO automated software, which is designed to detect suspected large-vessel occlusions (LVOs). The software may aid the ...

Clinicians are still at liberty to use medical products outside the labeled indication for use, but the U.S. FDA believes radiologists may be unaware of the limitations of radiological computer-aided ...